Id |
Subject |
Object |
Predicate |
Lexical cue |
T31 |
3-7 |
IN |
denotes |
with |
T32 |
8-12 |
JJ |
denotes |
high |
T33 |
13-21 |
NN |
denotes |
fatality |
T34 |
22-27 |
NNS |
denotes |
rates |
T35 |
28-31 |
CC |
denotes |
and |
T36 |
32-40 |
JJ |
denotes |
pandemic |
T37 |
41-50 |
NN |
denotes |
potential |
T38 |
52-59 |
NN |
denotes |
Vaccine |
T39 |
60-71 |
NN |
denotes |
development |
T40 |
72-79 |
VBZ |
denotes |
focuses |
T41 |
80-82 |
IN |
denotes |
on |
T42 |
83-86 |
DT |
denotes |
the |
T43 |
87-96 |
JJ |
denotes |
principal |
T44 |
97-103 |
NN |
denotes |
target |
T45 |
104-106 |
IN |
denotes |
of |
T46 |
107-110 |
DT |
denotes |
the |
T47 |
111-123 |
VBG |
denotes |
neutralizing |
T48 |
124-131 |
JJ |
denotes |
humoral |
T49 |
132-138 |
JJ |
denotes |
immune |
T50 |
139-147 |
NN |
denotes |
response |
T51 |
147-148 |
-COMMA- |
denotes |
, |
T52 |
149-152 |
DT |
denotes |
the |
T53 |
153-158 |
NN |
denotes |
spike |
T54 |
159-160 |
-LRB- |
denotes |
( |
T55 |
160-161 |
NN |
denotes |
S |
T56 |
161-162 |
-RRB- |
denotes |
) |
R29 |
T35 |
T31 |
arg2Of |
and,with |
R30 |
T34 |
T32 |
arg1Of |
rates,high |
R31 |
T34 |
T33 |
arg1Of |
rates,fatality |
R32 |
T34 |
T35 |
arg1Of |
rates,and |
R33 |
T37 |
T35 |
arg2Of |
potential,and |
R34 |
T37 |
T36 |
arg1Of |
potential,pandemic |
R35 |
T39 |
T38 |
arg1Of |
development,Vaccine |
R36 |
T39 |
T40 |
arg1Of |
development,focuses |
R37 |
T40 |
T41 |
arg1Of |
focuses,on |
R38 |
T44 |
T41 |
arg2Of |
target,on |
R39 |
T44 |
T42 |
arg1Of |
target,the |
R40 |
T44 |
T43 |
arg1Of |
target,principal |
R41 |
T44 |
T45 |
arg1Of |
target,of |
R42 |
T50 |
T45 |
arg2Of |
response,of |
R43 |
T50 |
T46 |
arg1Of |
response,the |
R44 |
T50 |
T47 |
arg1Of |
response,neutralizing |
R45 |
T50 |
T48 |
arg1Of |
response,humoral |
R46 |
T50 |
T49 |
arg1Of |
response,immune |
R47 |
T50 |
T51 |
arg1Of |
response,"," |
R51 |
T53 |
T54 |
arg1Of |
spike,( |
R52 |
T55 |
T54 |
arg2Of |
S,( |
R53 |
T56 |
T54 |
arg3Of |
),( |